Form 4: Sarepta Therapeutics Executive Bilal Arif Reports Stock Disposals to Cover Tax Obligations
SEC Form 4
Bilal Arif, Chief Tech Ops Officer of Sarepta Therapeutics, reports the disposal of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 4, 2025, Bilal Arif, Chief Tech Ops Officer of Sarepta Therapeutics, disposed of 281 shares of common stock at a price of $101.34.
- Additionally, on the same day, Arif disposed of another 233 shares of common stock, also at $101.34.
- These disposals were made to satisfy tax withholding obligations related to the vesting of restricted stock units granted on March 3, 2021.
- Following these transactions, Arif beneficially owns 16,282 shares of Sarepta Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, allowing investors to track executive sentiment and potential alignment with shareholder interests.
Stakeholder Impact
- The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but it is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/03/2021 | Date of restricted stock units grant. |
| 03/04/2025 | Date of stock disposal to cover tax obligations. |
| 03/06/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.